Post-caesarean section analgesia: efficacy of in-wound infusion for levobupivacaine and ketorolac

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006559

Enrollment

Registered

2014-07-30

Start date

2012-01-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia after c-section O82

Interventions

Group 1: in-wound catheter with elastomeric pump ( On Q Pain Buster 270 ml) for continuous infusion 5 ml/h over the fascia, for 48 hours - group 1: 0,25% levobupivacaine Group 2: - in-wound cathete

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: first caesarean section, non-emergency; 37 or more weeks of pregnancy, ASA 1 and 2; no contraindications for regional anaesthesia; no allergy to local anaesthetics, NSAID drugs or paracetamol;

Exclusion criteria

Exclusion criteria: - previous big abdominal operations, - BMI 30 or more before conception; - drug or alcochol abuse, - ASA 3 or more; - allergy: local anaesthetics, NSAID, paracetamol

Design outcomes

Primary

Measure	Time frame
consumption of opioid piritramid in miligrams in 24 and 48 hours; writing on a check-list	—

Secondary

Measure	Time frame
Pain:VAS score at 1st, 3rd,6th, 12th, 18th, 24th, 36th, 48th hour ; microbiological test of catheters, persistent pain after 8 weeks post C-section	—

Countries

Slovenia

Contacts

Public ContactJožica Wagner Kovacec

SZAIM Slovenia

jozica.wagner-kovacec@guest.arnes.si+38641609305

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026